Silverfin false false 30/09/2024 30/09/2024 01/10/2023 The principal activity of the Company during the financial year was specialists medical practice activities. Dr James Swee Beng Kho 16/09/2022 Fang En Sin 16/09/2022 14361627 2024-09-30 14361627 bus:Director1 2024-09-30 14361627 bus:Director2 2024-09-30 14361627 2023-09-30 14361627 core:CurrentFinancialInstruments 2024-09-30 14361627 core:CurrentFinancialInstruments 2023-09-30 14361627 2023-10-01 2024-09-30 14361627 bus:Micro-entities 2023-10-01 2024-09-30 14361627 bus:FilletedAccounts 2023-10-01 2024-09-30 14361627 bus:AuditExemptWithAccountantsReport 2023-10-01 2024-09-30 14361627 bus:PrivateLimitedCompanyLtd 2023-10-01 2024-09-30 14361627 bus:Director1 2023-10-01 2024-09-30 14361627 bus:Director2 2023-10-01 2024-09-30 14361627 2022-09-16 2023-09-30 iso4217:GBP xbrli:pure

Company No: 14361627 (England and Wales)

# SEVERN HEALTH LIMITED

### Unaudited Financial Statements
For the financial year ended 30 September 2024
Pages for filing with the registrar

SEVERN HEALTH LIMITED

## UNAUDITED FINANCIAL STATEMENTS

For the financial year ended 30 September 2024

Contents

SEVERN HEALTH LIMITED

## BALANCE SHEET

As at 30 September 2024
SEVERN HEALTH LIMITED

## BALANCE SHEET (continued)

For the financial year ended 30 September 2024

|  | 30.09.2024 |  | 30.09.2023
|  | £ |  | £
Fixed assets |  | 675 |  | 489
Current assets |  | 76,626 |  | 28,331
Creditors: amounts falling due within one year |  | ( 11,040) |  | ( 5,129)
Net current assets |  | 65,586 |  | 23,202
Total assets less current liabilities |  | 66,261 |  | 23,691
Accruals and deferred income |  | ( 1,513) |  | ( 1,753)
Net assets |  | 64,748 |  | 21,938
Capital and reserves |  | 64,748 |  | 21,938

For the financial year ending 30 September 2024 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

- The members have not required the Company to obtain an audit of its financial statements for the financial year in accordance with section 476;
- The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements;
- These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and FRS 105 The Financial Reporting Standard applicable to the Micro-entities Regime;
- These financial statements have been delivered in accordance with the small companies regime and a copy of the Profit and Loss Account has not been delivered.

The financial statements of Severn Health Limited (registered number: 14361627) were approved and authorised for issue by the Board of Directors on 01 September 2025 and were signed on its behalf by:

Dr James Swee Beng Kho Director |

SEVERN HEALTH LIMITED

## NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 30 September 2024
SEVERN HEALTH LIMITED

## NOTES TO THE FINANCIAL STATEMENTS (continued)

For the For the financial year ended 30 September 2024

#### 1. Company information

The Company is a private company limited by shares and is incorporated in the United Kingdom and registered in England and Wales (Company no. 14361627). The address of its registered office is 5th Floor 25 King Street, Bristol, BS1 4PB, United Kingdom.

#### 2. Employees

| Year ended 30.09.2024 |  | Period from 16.09.2022 to 30.09.2023
| Number |  | Number
Monthly average number of persons employed by the Company during the financial year, including directors | 2 |  | 2